Balancing the upside and downside of antiretroviral therapy in children.
暂无分享,去创建一个
[1] Y. Maldonado,et al. Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohort. , 2005, JAMA.
[2] P. Williams,et al. Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trials to clinical practice. , 2005, JAMA.
[3] L. Mofenson,et al. A trial of three antiretroviral regimens in HIV-1-infected children. , 2004, The New England journal of medicine.
[4] L. D'Angelo,et al. A family group approach to increasing adherence to therapy in HIV-infected youths: results of a pilot project. , 2003, AIDS patient care and STDs.
[5] A. Wu,et al. Adherence to Antiretroviral Therapy: Where Are We, and Where Do We Go From Here? , 2002, Journal of acquired immune deficiency syndromes.
[6] D. Vlahov,et al. A PROSPECTIVE STUDY OF ADHERENCE AND VIRAL LOAD IN A LARGE MULTI-CENTER COHORT OF HIV-INFECTED WOMEN , 2002, AIDS.
[7] V. Stone,et al. Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] E. Morse,et al. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. , 2002, Pediatrics.
[9] V. Idemyor. Continuing debate over HIV therapy initiation , 2002, HIV clinical trials.
[10] D. Murphy,et al. The TREAT (Therapeutic Regimens Enhancing Adherence in Teens) program: theory and preliminary results. , 2001, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[11] J. Church. Reducing the Odds — Preventing Transmission of HIV in the United States , 2001, Journal of Perinatology.
[12] P. Sriskandabalan,et al. Self-medication with zidovudine that was not , 2001, The Lancet.
[13] K. Hertogs,et al. High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Côte d'Ivoire. , 2001 .
[14] G. Zissis,et al. Effectiveness of antiretroviral therapy initiated before the age of 2 months in infants vertically infected with human immunodeficiency virus type 1 , 2000, European Journal of Pediatrics.
[15] Susan Swindells,et al. Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection , 2000, Annals of Internal Medicine.
[16] S. Lee,et al. Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team. , 2000, JAMA.
[17] G. Luftman,et al. Antiretroviral adherence issues among HIV-positive adolescents and young adults. , 1999, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[18] J. Farley,et al. Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1. , 1999, The Pediatric infectious disease journal.
[19] M. Gersten,et al. Treatment of human immunodeficiency virus 1-infected infants and children with the protease inhibitor nelfinavir mesylate. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] M. Gwinn,et al. Projection of AIDS and HIV incidence among children born infected with HIV. , 1998, Statistics in medicine.